Latest NewsApr 29, 2025HiFiBiO Therapeutics to Present Preclinical Data for A Novel Immunology Antibody at the 2025 Annual Meeting of the Clinical Immunology Society All Filter By: Year20252024202320222021202020192018201720162015PharmaBoardRoom Article | Article | Mar 8, 2021HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by PharmaBoardRoom and Genialis PodcastOct 27, 2020HiFiBiO Therapeutics CEO Liang Schweizer Named one of the World’s Top Female FoundersOct 26, 2020HiFiBiO Therapeutics Completes First Cohort of a Phase I Study of its SARS-CoV-2 Neutralizing Antibody for the Treatment and Prevention of COVID-19Sep 24, 2020HiFiBiO Therapeutics CEO Liang Schweizer Receives 2020 Extraordinary Women Advancing Healthcare AwardSep 17, 2020HiFiBiO Therapeutics Presents Novel Approach to Patient Stratification Demonstrating DIS® Single-Cell Platform at 2020 AACR Tumor Heterogeneity Conference< 1 … 8 9 10 11 12 … 17 >